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Channels in HEK293 Cells*
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A cDNA encoding a G-protein-coupled receptor was
cloned from the central nervous system of the pond snail
Lymnaea stagnalis. The predicted amino acid sequence
of this cDNA most closely resembles the Drosophila ty-
ramine/octopamine receptor, the Locusta tyramine re-
ceptor, and an octopamine receptor (Lym oa1) that we
recently cloned from Lymnaea. After stable expression
of the cDNA in HEK293 cells, we found that [3H]rauwol-
scine binds with high affinity to the receptor (KD 5
6.2z1029 M). Octopamine appears to be the most potent
naturally occurring agonist to displace the [3H]rauwol-
scine binding (Ki 5 3.0z10
27 M). Therefore, the receptor is
considered to be an octopamine receptor and is conse-
quently designated Lym oa2. The novel receptor shares
little pharmacological resemblance with Lym oa1, indi-
cating that the two receptors represent different octo-
pamine receptor subfamilies. Octopaminergic stimula-
tion of Lym oa2 does not induce changes in intracellular
concentrations of cAMP or inositol phosphates. How-
ever, electrophysiological experiments indicate that oc-
topamine is able to activate a voltage-independent Cl2
current in HEK293 cells stably expressing Lym oa2. Al-
though opening of this chloride channel most probably
does not require the activation of either protein kinase
A or C, it can be blocked by inhibition of protein
phosphorylation.
G-protein1-coupled receptors form a large superfamily of
membrane receptors that can be found in all species ranging
from unicellular eukaryotes to mammals and that can interact
with a large variety of signals (e.g. light, odorants, Ca21, bio-
genic amines, glycoprotein hormones, etc.) (1).
Bioamines like dopamine, epinephrine, norepinephrine, and
octopamine all interact with specific G-protein-coupled recep-
tors. Dopamine is present in high amounts in both vertebrate
and invertebrate species. Epinephrine and norepinephrine, on
the other hand, are present predominantly in vertebrates,
whereas octopamine is considered to act as a major neurotrans-
mitter in invertebrate species only. Octopamine is often re-
ferred to as the invertebrate counterpart of norepinephrine
because of the structural similarity between these neurotrans-
mitters (they differ only in the presence of a single catecholic
hydroxyl group) as well as their functional similarity (both
serve an important role in stress adaptation) (2). Consequently,
the adrenergic and octopaminergic receptors share pharmaco-
logical as well as structural properties (3, 4).
The role of octopamine as a neurotransmitter has been stud-
ied particularly well in insects, where it has been shown to
interact with at least four different octopamine receptor sub-
types (3). The central nervous systems of a number of snails
have also been used to study octopaminergic neurotransmis-
sion. The presence of octopamine has been demonstrated in the
sea slug Aplysia (5–7), the land snail Helix (8, 9), and the pond
snail Lymnaea (10). In these species, the interactions of octo-
pamine with its receptors have been described mainly at the
electrophysiological level (7, 8, 11–15). In general, application
of octopamine induces a hyperpolarization of susceptible snail
neurons, a process that is thought to be mediated by an in-
crease in cAMP (2, 11, 12), leading to an increased potassium
(12–14) or calcium (15) conductance. In addition, a pharmaco-
logical characterization of octopamine receptors has been de-
scribed for Lymnaea.2
We have recently cloned and characterized a cDNA encoding
an octopamine receptor expressed in the brain of Lymnaea
stagnalis (16). This receptor (Lym oa1) shows moderate homol-
ogy to the Drosophila tyramine/octopamine receptor (17, 18), to
the Locusta tyramine receptor (19) and to the vertebrate a-ad-
renergic receptors. Activation of this receptor, when expressed
in human embryonic kidney (HEK293) cells, leads to elevated
concentrations of both intracellular inositol phosphates and
cAMP. The pharmacological profile of Lym oa1 suggests that
this receptor represents a previously unknown octopamine re-
ceptor subtype.
This paper describes the structure of a second octopamine
receptor cDNA (Lym oa2) cloned from Lymnaea. The predicted
amino acid sequence of this receptor only shows limited simi-
larity to Lym oa1, as well as to the insect tyramine receptors
and the a-adrenergic receptors. Its pharmacological profile
clearly differs from that of previously described receptors.
When the novel receptor is stably expressed in HEK293 cells,
application of octopamine does not lead to changes in the in-
tracellular concentration of cAMP or inositol phosphates. Acti-
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vation of Lym oa2 does, however, induce a long lasting opening
of Cl2 channels. G-protein-mediated activation of a similar Cl2
current was recently described by Postma et al. (20) in rat
fibroblasts. Their study also indicated that none of the known
second messenger system was involved in the Cl2 channel
activation. Nevertheless, it was suggested that the increase in
chloride conductance was closely associated with the activation
of phosphoinositide hydrolysis. In contrast, our results clearly
indicate that this novel signaling pathway functions independ-
ently from the activation of phospholipase C (PLC). We further
show that although protein kinase A and protein kinase C are
most probably not involved in the signaling pathway, protein
phosphorylation is important for the opening of the Cl2
channel.
FIG. 1. Nucleotide and deduced amino acid sequence Lym oa2
cDNA. Putative transmembrane regions are boxed. Residues in filled
squares represent consensus sites for N-linked glycosylation; residues
in filled circles represent consensus phosphorylation sites for protein
kinase C. Residues in open circles have been implicated in bioamine
binding. The serine residue in an open square can be phosphorylated by
protein kinase A. Restriction sites that have been used for the cloning
of the expression construct are depicted in bold italics.
FIG. 2. Saturable binding of [3H]rauwolscine to Lym oa2 stably
expressed in HEK293 cells. Inset, Scatchard plot of the same data.
SB, specific binding in picomoles/mg of protein. SB represents the total
binding minus the nonspecific binding of [3H]rauwolscine to mem-
branes of HEK293 cells expressing Lym oa2. Nonspecific binding was
determined by displacement of [3H]rauwolscine binding by mianserin (5
mM). F, free [3H]rauwolscine.
TABLE I
Ki and pKi values of various compounds for Lym oa2 as determined by
displacement of [3H]rauwolscine binding (6 nM)
Ki values are given (6S.D.) as deduced from three independent ex-
periments, each performed in triplicate. The right column shows the pKi
values of Lym oa1 (16). These values were obtained in a method similar





Lym oa2 Lym oa1
Agonists
(6)-p-Synephrine 7.01 6 0.02 6.41 6 0.24
(6)-p-Octopamine 6.52 6 0.14 5.68 6 0.18
Xylometazoline 6.10 6 0.10 5.63 6 0.03
B-HT 920 5.93 6 0.20 4.80 6 0.11
(2)-Norepinephrine 5.71 6 0.05 4.09 6 0.39
Clonidine 5.70 6 0.01 6.57 6 0.32
(2)-Epinephrine 5.58 6 0.16 4.26 6 0.08
p-Tyramine 5.42 6 0.11 4.44 6 0.17
Phenylephrine 5.22 6 0.44 5.60 6 0.13
Oxymetazoline 5.19 6 0.05 5.56 6 0.08
Methoxamine 5.16 6 0.05 ,4
Dopamine 5.05 6 0.14 ,4
Serotonin 4.54 6 0.21 4.43 6 0.13
Histamine 4.03 6 0.18 ,4
Antagonists
Rauwolscine 7.99 6 0.08 7.46 6 0.02
Mianserin 7.94 6 0.25 7.67 6 0.34
Phentolamine 7.01 6 0.25 8.07 6 0.14
Chlorpromazine 6.66 6 0.28 8.53 6 0.26
Spiperone 6.31 6 0.05 8.50 6 0.31
Yohimbine 6.15 6 0.09 8.89 6 0.28
(2)-Propanolol 5.51 6 0.14 4.93 6 0.15
Alprenolol 5.42 6 0.12 5.01 6 0.41
Prazosine 4.71 6 0.19 7.02 6 0.05
Pindolol 4.34 6 0.46 4.56 6 0.12
















Isolation of the cDNA Encoding Lym oa2—Central nervous systems
of adult L. stagnalis bred in the laboratory (21) were dissected, the total
RNA was isolated (22), and cDNA was transcribed using oligo(dT)
primers and SuperScript™ RNase H2 reverse transcriptase (Life Tech-
nologies, Inc.). This cDNA served as a template in a degenerate PCR
strategy designed to isolate genes encoding G-protein-coupled bioamine
receptors. The oligonucleotide primers recognize stretches of conserved
amino acid residues present in transmembrane (TM) regions 6 and 7
and have been described previously (23). PCR products were cloned and
sequenced (Sequenase, Life Technologies, Inc.), and one of the frag-
ments revealed significant similarity to the TM6–TM7 region of adre-
nergic receptors. The presence of several large cDNA clones correspond-
ing to this initial fragment was confirmed in a PCR-based screening of
a fractionated Lymnaea central nervous system cDNA library in l-ZAP.
Isolated single plaques containing the full-length cDNA inserts were
converted into pBS-SK2 phagemids (designated pBS-Lym oa2) by in
vivo excision, and the insert was sequenced (Sequenase, Life Technol-
ogies, Inc.).
Stable Expression of Lym oa2 in HEK293 Cells—A PCR fragment
covering the 59 part of the open reading frame of pBS-Lym oa2 was
generated using a sense oligonucleotide based on the DNA sequence
around the start codon of the open reading frame and an antisense
oligonucleotide based on the sequence 39 from the endogenous KpnI site
(located at position 563; see Fig. 1). This fragment was cloned, se-
quenced on both strands, and combined with the 39-coding region of
Lym oa2 obtained as a KpnI and XbaI fragment (XbaI site located at
position 1931; see Fig. 1). The total coding region was cloned into
pcDNA3 (Invitrogen), yielding a construct designated pcDNA-Lym oa2.
HEK293 cells were stably transfected with pcDNA-Lym oa2 as de-
scribed before (16). The level of expression of Lym oa2 was determined
by measuring the binding of [3H]rauwolscine (81–85 Ci/mmol; Amer-
sham Corp.) to membrane preparations of resistant colonies. One cell
line exhibiting a Bmax of 2.2 pmol/mg was selected for further study.
Radioligand Binding Assays—The preparation of membranes of
HEK293 cells and the radioligand binding experiments were carried out
as described previously (16).
Saturation isotherms were obtained by incubating membrane pro-
tein with increasing amounts of [3H]rauwolscine (0.1–45 nM). Nonspe-
cific binding was determined by the addition of mianserin to a final
concentration of 5 mM.
Competition curves were obtained by incubating membrane protein
with 6 nM [3H]rauwolscine and increasing amounts of competitor
(10210–1024 M). The obtained data were fitted using Kaleidagraph 3.0
(Abelbeck Software) as described previously (16).
Measurements of Inositol Phosphate Formation—HEK293 cells were
grown to 6 50% confluency in 24-well plates, and incubated with 1 mCi
of myo-[3H]inositol (18 Ci/mmol, Amersham Corp.) per ml of inositol-
free Dulbecco’s modified Eagle’s medium (Life Technologies, Inc.) for
20–24 h. Cells were incubated with agonists in the presence of LiCl (10
mM) for 60 min at 37 °C. Cells were lysed with chloroform:methanol,
and total cellular inositol phosphates were extracted using Dowex AG
1-X8 anion exchange resin as described previously (16).
Measurements of Cyclic AMP Formation—HEK293 cells were grown
to 680% confluency in 24-well plates and incubated with agonists and
300 mM 3-isobutyl-1-methylxanthine for 20 min at 37 °C. The medium
was aspirated and the cells were lysed by sonication in 200 ml of ice-cold
0.1 N HCl. Then, 75 ml of neutralization buffer (230 mM NaOH, 560 mM
Tris, 140 mM NaCl, 56 mM EDTA, 0.35 M HEPES) was added, and the
concentration of cAMP was determined as described previously (25).
Electrophysiological Experiments—For electrophysiological record-
ings, HEK293 cells were kept in Petri dishes (Costar) and bathed in 140
mM NaCl, 2.8 mM KCl, 1 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, 10 mM
glucose, pH 7.2, adjusted with NaOH. The composition of standard
(non-selective) pipette solution was 135 mM KCl, 1 mM CaCl2, 10 mM
EGTA, 10 mM HEPES, 2 mM MgATP, 0.1 mM Tris-GTP, pH 7.2, ad-
justed with KOH. To test whether currents were carried by Cl2 ions,
KCl in the pipette solution was replaced by K1-aspartate. Agonists
were administered by means of a pico-spritzer (General Valve, Fair-
field, U. S. A.) using a small glass pipette (tip diameter 20 mm) placed
at a distance of ;100 mm from the recorded cell. This setup enabled
rapid application of drugs (,, 1 s).
Whole cell voltage clamp experiments were performed using either
an Axoclamp 2A amplifier (Axon Instruments, Inc., Foster City, CA) in
the continuous single electrode voltage clamp mode, in which case cell
capacitance (;60 picofarads) was not compensated, or a Liszt EPC7
amplifier (Liszt, Darmstadt, Germany), allowing cell capacitance com-
pensation. Pipettes (2–6 MV) were pulled on a Flaming/Brown P-87
(Sutter Instrument Co.) horizontal micro-electrode puller from Clark
GC-150 glass (Clark Electromedical Instruments, UK; seal resistance,
.2 GV). After disruption of the patch membrane, series resistance (,6
MV) was compensated for ;70%. Measurements commenced 5 min
after access to the cell to allow equilibration with the pipette solution.
Data acquisition was controlled by a CED 1400 AD/DA converter (Cam-
bridge Electronics Design, Cambridge, UK) connected to an Intel 80486-
based computer run with voltage clamp software developed in our
laboratory. The current recordings were filtered at 1–5 kHz, sampled at
1 kHz, and stored on line. This system allowed simultaneous applica-
tion of voltage steps, acquisition of current recordings, and timed ap-
plication of drugs.
RESULTS
Cloning of Lym oa2 cDNA—We have applied the PCR tech-
nique to clone G-protein-coupled receptors that are expressed
in the brain of L. stagnalis, using degenerated primers based
on highly conserved sequences present in TM6 and TM7 of
G-protein-coupled receptors. The obtained PCR products were
sequenced and these sequences were conceptually translated.
One derived amino acid sequence showed considerable similar-
ity to the sequence of the corresponding region in catecholamin-
ergic receptors. We isolated and sequenced the corresponding
full-length cDNA from a Lymnaea central nervous system li-
brary (see Fig. 1). An open reading frame that can encode a
protein of 578 amino acids is present on this cDNA (see Fig. 1).
FIG. 3. Comparison of the pharmacological properties of Lym oa1 and Lym oa2. A, comparison of pKi values of agonists for both
octopamine receptors; pKi values of ,4 are not included in the graph. B, comparison of pKi values of antagonists for both receptors. For binding
conditions and numbering of compounds, see Table I.















The presence of seven hydrophobic regions characteristic for
G-protein-coupled receptors can clearly be recognized within
the predicted amino acid sequence. Within these regions, the
most prominent amino acid identity is found with the Drosoph-
ila tyramine/octopamine receptor (49%) (17, 18), the Locusta
tyramine receptor (50%) (19), Lym oa1 (45%), and the mamma-
lian a2-adrenoreceptors (641%), thus confirming that the open
reading frame is likely to code for a bioamine receptor.
Stable Expression and Pharmacological Characterization of
Lym oa2—To further delineate the nature of this receptor we
stably expressed it in HEK293 cells. We then used the binding
of [3H]rauwolscine to membranes of these cells as a marker to
select clonal lines expressing high levels of receptor protein.
One clone, exhibiting a Bmax of 2.2 pmol/mg, was chosen for a
pharmacological characterization of the receptor. Fig. 2 shows
the saturation binding curve and the corresponding Scatchard
plot of the binding of [3H]rauwolscine. The affinity constant
(KD) of [
3H]rauwolscine for the novel receptor is 6.24 nM. The
ability of several (mainly adrenergic) compounds to displace
[3H]rauwolscine binding is presented in Table I. The rank order
of potencies of selected agonists is: (6)-p-synephrine . (6)-p-
octopamine . xylometazoline . (2)-norepinephrine 5
clonidine . epinephrine $ p-tyramine . dopamine. The rank
order of potencies of selected antagonists is: rauwolscine 5
mianserin . phentolamine . spiperone . yohimbine . (2)-
propanolol . prazosine . pindolol. Since octopamine is the
most potent naturally occurring agonist to displace the
[3H]rauwolscine binding, the receptor was considered to be an
octopamine receptor and consequently called Lym oa2.
We recently cloned and characterized another octopamine
receptor from Lymnaea (Lym oa1; Ref. 16). To allow for a
comparison of the binding properties of both octopamine recep-
tors, Table I also shows the pKi values of the same set of ligands
obtained by the displacement of [3H]rauwolscine binding from
Lym oa1. As can be seen from a Pearson correlation graph (Fig.
3) the pharmacological profiles of Lym oa1 and Lym oa2 are
considerably different.
Signal Transduction of Lym oa2—We tested to discover to
which signal transduction pathways Lym oa2 can be coupled.
In transiently transfected HEK293 cells, as well as in four
independently isolated stable cell lines, octopaminergic stimu-
lation did not induce any change in the concentration of cAMP
or inositol phosphates. Also, stimulation with tyramine, epi-
nephrine, norepinephrine, dopamine, serotonin, or histamine
did not change the concentration of these second messengers as
compared with non-transfected HEK293 cells. Positive control
experiments, however, resulted in pronounced increases in
cAMP or inositol phosphates (stimulation of endogenous b-ad-
renergic receptors increased cAMP 20-fold over basal levels,
and stimulation of Lym oa1 receptors expressed in HEK293
cells increased inositol phosphates 45-fold over basal levels;
data not shown).
Since activation of many neuronal receptors induces changes
in membrane conductances of the cells in which they are ex-
FIG. 4. Octopamine induces a spe-
cific inward current in Lym oa2-
transfected HEK293 cells. In these
whole cell voltage clamp experiments the
cells were kept at a holding potential of
280 mV, and voltage steps to test poten-
tials ranging from 250 to 150 mV were
given. Left and middle panels show the
holding current preceding each voltage
step and the family of responses to the
voltage steps of increasing amplitude. In
the right panels the holding current
(measured 10 ms before the onset of the
voltage step) is plotted as a function of
time. Application of agonist and antago-
nists is indicated by horizontal bars. A,
octopamine induces a sustained increase
in holding current but has little effect on
the voltage-dependent outward currents.
The current versus time plot shows that
the inward current response steadily in-
creases during a 3-min application (n 5
10). B, the octopamine response is mim-
icked by synephrine (n 5 6). C, the octo-
pamine response is blocked by yohimbine
(n 5 3). Subsequent application of only
octopamine restores the response. In A and
B cell capacitance was not compensated.















pressed, we tested whether application of octopamine to
HEK293 cells expressing Lym oa2 elicited electrical responses
in these cells. Application of 10 mM octopamine to HEK293 cells
expressing Lym oa2 induced a large but slow increase in the
holding current of the voltage-clamped cells (Fig. 4A). The
amplitude of the octopamine-induced current decreased at
more depolarized potentials. Application of synephrine (10 mM),
an agonist with a higher potency than octopamine (see Table I),
mimicked the octopamine-induced response, whereas yohim-
bine (10 mM), an antagonist, inhibited the response, thus con-
firming the specificity of the effect (see Fig. 4, B and C). Appli-
cation of octopamine to non-transfected HEK293 cells did not
show any effect (Fig. 7A).
In order to study the nature of the current (e.g. the voltage
dependence and ionic selectivity), we performed voltage ramp
experiments. Current responses were recorded while the volt-
age was continuously varied from 280 mV to 110 mV over a
period of 8 s, both in the absence and presence of octopamine
(Fig. 5A). The current voltage (IV) relation of the octopamine-
induced current was obtained by subtracting the control cur-
rent from the current response in the presence of octopamine.
Fig. 5B shows that octopamine activates a current response
over the whole voltage range tested and that the IV relation of
the octopamine-induced current is almost linear, indicating
that the current is voltage-independent. Comparison of the IV
relations of nonstimulated and stimulated cells revealed no or
only minor differences (,5 mV) in reversal potential (Fig. 5A).
The IV curve of the octopamine-induced current (isolated by
subtraction) showed reversal around 210 mV, which is close to
the reversal potential of chloride ions (ECl2 5 22 mV under the
present ionic conditions). To test whether the octopamine re-
sponse is indeed carried by Cl2 ions, we replaced KCl in the
intracellular (pipette) medium with K1-aspartate, thus shift-
ing ECl2 to 2108 mV. This change caused a dramatic loss of the
octopamine-induced inward current response (Fig. 5, C and D).
While under standard Cl2 conditions (measured at 290 mV)
octopamine induced an increase in inward current of 149 6 33
pA (n 5 6), this reversed to a negligible outward current of 13 6
7 pA (n 5 5) with aspartate replacing Cl2 in the pipette. This
result strongly suggests that octopamine activates chloride
channels.
We then performed a limited number of initial experiments
to study the signal transduction pathway underlying the acti-
vation of the Cl2 channel. The above experiments already
indicated that the process is slow; the current still increased 10
min after application of octopamine. To see whether a phospho-
rylation step is involved, we tested the effect of the nonspecific
protein kinase inhibitor H1004 on the octopamine-induced cur-
rent. Fig. 6 shows that in the presence of 50 mM H1004, octo-
pamine did not induce or only very slightly induced the inward
Cl2 current, whereas subsequent application of only octopa-
mine did evoke the normal response.
Interestingly, we observed that HEK293 cells stably express-
ing Lym oa1 showed the same current response to octopamine
as cells expressing Lym oa2 (Fig. 7B). The effect, however, is
not a general consequence of the activation of overexpressed,
heterologous receptors, since stimulation of a Lymnaea sero-
tonin receptor (5-HT2Lym) stably expressed in HEK293 cells
(23) did not show any effect on the Cl2 conductance (Fig. 7C).
Furthermore, stimulation of b-adrenergic receptors that are
endogenously present in HEK293 cells did not influence the
inward current (Fig. 7D). Stimulation of Lym oa1, Lym oa2,
5-HT2Lym, and b-AR all differentially influenced the outward
current. These effects, however, were not studied in detail.
DISCUSSION
We have used a degenerate PCR strategy to isolate cDNAs
encoding G-protein-coupled bioamine receptors that are ex-
pressed in the central nervous system of the pond snail L.
stagnalis. Recently, we reported the cloning and expression of
a serotonin receptor (5-HT2Lym; Ref. 23) and an octopamine
receptor (Lym oa1; Ref. 16) using the same strategy. This paper
describes the isolation of a cDNA encoding a second octopamine
receptor, designated Lym oa2. The predicted amino acid se-
quence of Lym oa2 exhibits the highest similarity to the Dro-
sophila tyramine/octopamine receptor, the Locusta tyramine
receptor, and Lym oa1, and to the vertebrate a-adrenergic
receptors. Although both Lym oa2 and Lym oa1 encode Lym-
naea octopamine receptors, their amino acid identity is only
moderate, i.e. 45% in the TM regions. An interesting difference
in the sequence of both octopamine receptors can be found in
TM5. Mutagenesis studies on catecholaminergic receptors have
indicated that two conserved serine residues in this domain
(Ser204 and Ser207 in the b-adrenergic receptor) play a crucial
role in ligand binding. Supposedly, the two Ser hydroxyl groups
can hydrogen bond to the catechol hydroxyl groups of the ligand
(see for instance Refs. 26–28). In octopamine receptors there is
FIG. 5. Octopamine activates a voltage-independent Cl2 cur-
rent. Current responses were recorded in experiments in which voltage
ramps were applied. Over a period of 8 s the voltage was continuously
varied from 280 to 110 mV. A, current responses in the absence (1) and
presence (2) of octopamine using standard salines with [Cl2]out 5 148.8
mM and [Cl2]in 5 137 mM, yielding a theoretical reversal potential for
Cl2 of 22 mV. B, current voltage relation of the isolated current re-
sponse to octopamine, obtained by subtraction of trace 1 from trace 2
from panel A. Reversal of the current response is close to the theoreti-
cally expected potential (n 5 6). C andD, like A and B, but with internal
Cl2 replaced by aspartate, thus shifting the Cl2 reversal potential to
2108 mV. Note the control response and the response in the presence of
octopamine overlap, indicating that, with aspartate in the cell, the
current response is eliminated (n 5 5).















no obvious need for conservation of both serine residues in TM5
because the aromatic ring of octopamine is monohydroxylated.
Indeed, in Lym oa1 only a single serine is found at the relevant
position in TM5. In Lym oa2, however, both serines are present.
Interestingly, the catecholamines (epinephrine, norepineph-
rine, dopamine) show a considerably higher affinity for Lym
oa2 than for Lym oa1 (see Table I). This suggests that the serine
residues in TM5 play a role in agonist binding in the Lymnaea
octopamine receptors similar to their role in the vertebrate
catecholamine receptors.
In general, agonists exhibit higher affinities for Lym oa2
than for Lym oa1, while antagonists have higher affinities for
Lym oa1 than for Lym oa2. Another interesting difference be-
tween the binding properties of both octopamine receptors is
the opposite order of affinities for the isoschizomers rauwol-
scine and yohimbine. Lym oa1 has a higher affinity for yohim-
bine than for rauwolscine (pKi 5 8.9 versus 7.5), while Lym oa2
has a higher affinity for rauwolscine than for yohimbine (pKi 5
8.0 versus 6.2). Both the pharmacological profiles of Lym oa1
and Lym oa2 indicate a closer relationship to the a-adrenergic
receptors than to the b-adrenergic receptors. In that respect it
is noteworthy to mention the much higher affinity of the a1
antagonist prazosine for Lym oa1 (pKi 5 7.0) than for Lym oa2
(pKi 5 4.7). Whereas the pharmacological profile of Lym oa1
still shows a moderate similarity to that of the Drosophila
tyramine/octopamine receptor, the Locusta tyramine receptor,
and the a2-adrenergic receptors, the pharmacological profile of
Lym oa2 clearly differs from that of Lym oa1, the tyramine
receptors, the adrenergic receptors, and the insect octopamine
receptor subtypes as described in tissue preparations.
Stimulation of Lym oa2 did not lead to the activation of the
classical signal transduction pathways mediated by adenylyl
cyclase and PLC. The receptor is, however, clearly able to
transduce signals since we found that HEK293 cells expressing
Lym oa2 showed octopamine-induced changes in their mem-
brane conductance. More specifically, we observed a slow but
large increase in the holding current of voltage-clamped
HEK293 cells upon application of octopamine. At potentials
below the Cl2 equilibrium potential, this response was ob-
served as an increase in inward current, most likely caused by
an efflux of Cl2 ions. The process underlying the opening of the
Cl2 channels may involve protein phosphorylation, since the
(nonselective) protein kinase inhibitor HA1004 inhibited the
inward current. Alternatively, the Cl2 channels involved may
need to be in a phosphorylated state to be able to open in
response to the octopamine stimulus. Because the IV relation-
ship of the current response proved to be linear and because no
changes in inositol phosphates were observed upon octopamine
application, the Cl2 channels involved are suggested to be both
voltage-independent and Ca21-independent. Additional effects
of octopamine on (voltage-dependent) outward currents were
also observed but were not pursued in detail.
Interestingly, stimulation of HEK293 cells expressing the
other Lymnaea octopamine receptor, Lym oa1, resulted in a
similar outward Cl2 current. In contrast to Lym oa2, Lym oa1
has previously been shown to activate both PLC and adenylyl
cyclase. To examine whether the effect on the Cl2 channel
might be secondary to the effects on adenylyl cylase and PLC or
might represent an independent signaling route, we tested the
effect of activation of two other receptors, expressed in HEK293
cells. Stimulation of these receptors, i.e. a Lymnaea serotonin
receptor or an endogenous b-adrenergic receptor, led to activa-
tion of PLC and adenylyl cyclase, respectively. The subsequent
rise in levels of diacylglycerol or cAMP will activate protein
kinase C or protein kinase A, respectively. Stimulation of these
receptors did, however, not show any effect on the inward
current, suggesting that protein kinase C or protein kinase A is
not involved in the phosphorylation process underlying Cl2
channel activation.
It remains to be investigated whether stimulation of Lym oa2
in Lymnaea neurons will also affect the Cl2 conductance. Ac-
tivation of octopamine receptors on neurons of other snails has
been described to lead to outward potassium currents (12–14)
and inward calcium currents (15). Early studies on Aplysia
FIG. 6. Blocking effect of HA1004 on
the octopamine response. A, voltage
clamp experiments as in Fig. 4. Left
panel, control. Middle panel, in the pres-
ence of the protein kinase blocker
HA1004, octopamine only induces a min-
imal inward current response. Right
panel, normal current response when only
octopamine is applied. B, current re-
sponse amplitude versus test pulse poten-
tial during control conditions, during oc-
topamine and HA1004 application, and
during application of only octopamine, as
indicated (n 5 3). Filled circles, maximal
outward current amplitude. Open circles,
amplitude of the holding current, meas-
ured 10 ms before onset of the responses
to the voltage steps.















octopamine receptors (29) have shown that stimulation of neu-
rons with octopamine induces the specific phosphorylation of a
particular unidentified protein. In this case, however, it was
suggested that the process might involve protein kinase A,
since elevating the intracellular concentration of cAMP pro-
duced a similar effect.
Recently, it was shown that activation of the G-protein-
coupled lysophosphatidic acid receptor present on fibroblasts
leads to a long lasting depolarization of these cells due to an
efflux of chloride ions (20). As was found in our studies, the
signal transduction pathway responsible for opening the chlo-
ride channel was suggested to be independent of known second
messengers. The opening of this particular chloride channel
could also be induced by activation of the thrombin receptor,
the endothelin receptor, and the neurokinin A receptor. Since
these receptors (as well as the lysophosphatidic acid receptor)
all couple to PLC, it was suggested that the signaling pathway
leading to the increased Cl2 conductance is closely associated
with phosphoinositide hydrolysis (20).
All available data suggest that the chloride channel in
HEK293 cells that we have found to be G-protein-activated is
highly similar to the channel described by Postma et al. (20).
Our data, however, exclude the option that phosphoinositide
hydrolysis is important in the signaling pathway leading from
the activated receptor to the opening of the chloride channel,
since stimulation of Lym oa2 does not result in any change in
intracellular concentrations of inositol phosphates. Also, acti-
vation of a serotonin receptor that has been shown to be cou-
pled to the activation of PLC does not influence the outward
Cl2 current. The G-protein-mediated activation of the chloride
channel described by Postma et al. in Rat-1 fibroblasts (20) and
by ourselves in HEK293 cells must proceed via an as yet
unknown signaling pathway. Here we show that protein phos-
phorylation is important in this pathway but that protein ki-
nase A and protein kinase C are not involved. The identifica-
tion of the relevant kinase and the further examination of the
signal transduction pathway will be the topics of future
investigations.
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FIG. 7. Effect of stimulation of other receptors on the inward
current, observed as an increase in the holding current preced-
ing the responses to a voltage step. A, application of octopamine to
non-transfected HEK293 cells fails to elicit a response (n 5 3). B,
application of octopamine to HEK293 cells expressing Lym oa1 induces
a similar response as in Lym oa2-transfected cells (n 5 5). C, application
of serotonin to HEK293 cells expressing 5-HT2Lym fails to elicit a similar
response (n 5 3). D, application of epinephrine to non-transfected
HEK293 cells, endogenously expressing b-adrenergic receptors, also
fails to elicit a similar response (n 5 2).
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